Page 55 - Noble-Virtual-Healthcare-2024

Zomedica Corp.

SELECTED FINANCIAL ITEMS ZOM

(in millions of USD)
CQ1 '23 CQ2 '23 CQ3 '23 CQ4 '23 LTM
Income Statement Key Items
Total Revenue 5.48 6.02 6.35 7.34 25.19
Gross Profit 3.84 4.05 4.36 5.07 17.32
Gross Margin 70% 67% 69% 69% 69%
EBIT (7.51) (6.74) (5.95) (11.39) (31.59)
EBIT Margin -137% -112% -94% -155% -125%
Net Income to Common Shareholders (6.39) (5.25) (0.49) (22.41) (34.53)
Net Margin -116% -87% -8% -305% -137%

Balance Sheet Key Items
Total Assets 279.60 274.78 275.05 253.20 253.20
Cash & Short Term Investments 8.35 27.95 21.78 12.95 12.95
% of Assets 3% 10% 8% 5% 5%
Current Assets -Total 130.16 139.63 115.39 99.88 99.88
% of Assets 47% 51% 42% 39% 39%
Total Liabilities 16.54 15.30 14.17 13.18 13.18
% of Assets 6% 6% 5% 5% 5%
Current Liabilities - Total 8.60 7.21 6.74 9.03 9.03
% of Assets 3% 3% 2% 4% 4%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity 263.06 259.48 260.88 240.02 240.02
% of Assets 94% 94% 95% 95% 95%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (4.26) (3.68) (3.03) (5.02) (15.98)
Net Cash Flow - Investing (14.79) 23.32 (3.12) (3.83) 1.58
Net Cash Flow - Financing NA NA NA NA 0.00

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference